(Q32021536)

5 July 2017

1 reference

title

Metabolic management of ischemic heart disease: clinical data with trimetazidine (English)

1 reference

5 July 2017

main subject

coronary artery disease

1 reference

Desideri A

1

1 reference

5 July 2017

Celegon L

series ordinal

2

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

American Journal of Cardiology

5 July 2017

published in

1 reference

5 July 2017

volume

82

1 reference

5 July 2017

issue

5A

1 reference

5 July 2017

page(s)

50K-53K

1 reference

The mechanism of myocyte death in ischaemia

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Acute effects of trimetazidine evaluated by exercise testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Combination of trimetazidine with nifedipine in effort angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900537-2

10.1016/S0002-9149(98)00537-2

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference